Clinical trials for Desmoid tumor
18 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 2NCT07541430A Study in Adults With Desmoid TumorsElpiscience (Suzhou) Biopharma, Ltd.
- RECRUITINGPhase 4NCT07176689Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)SpringWorks Therapeutics, Inc. · PI: Winette van der Graff, MD
- ACTIVE NOT RECRUITINGPhase 2NCT07170644A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)SpringWorks Therapeutics, Inc.
- RECRUITINGNCT06945887Treatment of Desmoid Fibromatosis With Arterial EmbolizationIstituto Ortopedico Rizzoli
- RECRUITINGNCT07496242Immunological Phenotype of Desmoid-fibromatosis-affected Patients.Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · PI: Chiara Colombo, MD, Surgical Oncologist
- RECRUITINGPhase 2NCT05879146Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical StudyM.D. Anderson Cancer Center · PI: Keila Torres, MD,PHD
- RECRUITINGNCT06660121Electrochemotherapy for Desmoid TumorsIstituto Ortopedico Rizzoli · PI: Giancarlo Facchini, Medicine and Surgery
- RECRUITINGN/ANCT06081400Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful WaitingUniversity Hospital, Strasbourg, France · PI: Afshin GANGI, MD, PhD
- RECRUITINGNCT06268457Arterial Chemoembolization for the Treatment of Desmoid FibromatosisIstituto Ortopedico Rizzoli
- RECRUITINGNCT06224283Radiomics Compared With Conventional Response Criteria for Predicting Progression of Desmoid Tumor After CryoablationIstituto Ortopedico Rizzoli
- RECRUITINGPhase 2NCT05949099Study of Cryoablation and Nirogacestat for Desmoid TumorNam Bui · PI: Nam Bui, M.D.
- RECRUITINGN/ANCT05111964HIFU Ablation of Soft Tissue SarcomaOxford University Hospitals NHS Trust · PI: Paul C Lyon, FRCR, DPhil
- RECRUITINGN/ANCT05091255Cryotherapy in the Treatment of Desmoid TumorsIstituto Ortopedico Rizzoli
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT04871282A Study of AL102 in Patients With Progressing Desmoid TumorsImmunome, Inc. · PI: Mrinal Gounder, MD
- ACTIVE NOT RECRUITINGPhase 2NCT04195399A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by SurgeryChildren's Oncology Group · PI: Fariba Navid
- RECRUITINGNCT04281381Observing People With Desmoid-Type FibromatosisMemorial Sloan Kettering Cancer Center · PI: Aimee M Crago, MD, PhD
- ACTIVE NOT RECRUITINGN/ANCT02867033National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)Centre Oscar Lambret · PI: Nicolas PENEL, PhD
- RECRUITINGPhase 2NCT01898416Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumorsmichal roll · PI: Jacob Bickels, MD/PhD